Published : Jan-2020
No. of Pages : 50
1.1 List of Tables
1.2 List of Figures
2 Type 2 Diabetes: Executive Summary
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Reports
3 Epidemiology
3.1 Disease Background
3.2 Risk Factors and Comorbidities
3.3 Global and Historical Trends
3.4 Forecast Methodology
3.4.1 Sources
3.4.2 Forecast Assumptions and Methods: Diagnosed Prevalent Cases of T2D
3.4.3 Forecast Assumptions and Methods: Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D
3.4.4 Forecast Assumptions and Methods: Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D
3.4.5 Forecast Assumptions and Methods: Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
3.4.6 Forecast Assumptions and Methods: Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D
3.4.7 Forecast Assumptions and Methods: Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D
3.4.8 Forecast Assumptions and Methods: Prevalent Cases of Atherosclerosis Among the Diagnosed Prevalent Cases of T2D
3.5 Epidemiological Forecast for Type 2 Diabetes (2018-2028)
3.5.1 Diagnosed Prevalent Cases of T2D
3.5.2 Age-Specific Diagnosed Prevalent Cases of T2D
3.5.3 Sex-Specific Diagnosed Prevalent Cases of T2D
3.5.4 Comorbidities Among the Diagnosed Prevalent Cases of T2D
3.6 Discussion
3.6.1 Epidemiological Forecast Insight
3.6.2 Limitations of the Analysis
3.6.3 Strengths of the Analysis
4 Appendix
4.1 Bibliography
4.2 About the Authors
4.2.1 Epidemiologist
4.2.2 Reviewers
4.2.3 Global Director of Therapy Analysis and Epidemiology
4.2.4 Global Head and EVP of Healthcare Operations and Strategy
4.3 About GlobalData
4.4 Contact Us
4.5 Disclaimer
List of Tables
Table 1: Summary of Newly Added Data Types
Table 2: Summary of Updated Data Types
Table 3: Risk Factors and Comorbidities for T2D
List of Figures
Figure 1: 9MM, Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018 and 2028
Figure 2: 9MM, Diagnosed Prevalence of T2D (%), Men, All Ages, 2018
Figure 3: 9MM, Diagnosed Prevalence of T2D (%), Women, All Ages, 2018
Figure 4: 9MM, Sources Used and Not Used to Forecast Diagnosed Prevalent Cases of T2D
Figure 5: 9MM, Sources Used to Forecast the Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D
Figure 6: 9MM, Sources Used to Forecast the Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D
Figure 7: 9MM, Sources Used to Forecast the Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D
Figure 8: 9MM, Sources Used to Forecast the Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D
Figure 9: 9MM, Sources Used to Forecast the Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D
Figure 10: 9MM, Sources Used to Forecast the Prevalent Cases of Atherosclerosis Among the Diagnosed Prevalent Cases of T2D
Figure 11: 9MM, Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 12: 9MM, Age-Specific Diagnosed Prevalent Cases of T2D, Both Sexes, N, 2018
Figure 13: 9MM, Sex-Specific Diagnosed Prevalent Cases of T2D, All Ages, N, 2018
Figure 14: 9MM, Prevalent Cases of CKD Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 15: 9MM, Prevalent Cases of CVD Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 16: 9MM, Prevalent Cases of Obesity Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 17: 9MM, Prevalent Cases of Hypertension Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 18: 9MM, Diagnosed Prevalent Cases of Dyslipidemia Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
Figure 19: 9MM, Prevalent Cases of Atherosclerosis Among the Diagnosed Prevalent Cases of T2D, Both Sexes, All Ages, N, 2018
